DUBLIN–(BUSINESS WIRE)–The “North America Active Pharmaceutical Ingredients Market 2021-2028” report has been added to ResearchAndMarkets.com’s offering.
North America active pharmaceutical ingredients market is projected to grow by 5.3% annually in the forecast period and reach $111.44 billion by 2028, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population.
Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2028 with 2021 as the base year.
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Five Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America active pharmaceutical ingredients market in every aspect of the classification from perspectives of Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Country.
Based on Synthesis, the North America market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section.
Synthetic API
- Branded Synthetic API
- Generic Synthetic API
Biotech API by Drug Type:
- Monoclonal Antibodies
- Recombinant Proteins
- Vaccines
- Other Biotech APIs
Biotech API by Customer Base:
- Innovative Biologic API
- Generic Biosimilar API
Biotech API by Expression Technology:
- Mammalian Expression
- Microbial Expression
- Yeast Expression
- Insect Expression
- Other Expression Technologies
HPAPI
- Branded HPAPI
- Generic HPAPI
Based on Manufacturing Process, the North America market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section.
Captive Manufacturing
- Branded Captive API
- Generic Captive API
Merchant Manufacturing by Drug Type:
- Branded Merchant API
- Generic Merchant API
Merchant Manufacturing by Drug Synthesis:
- Merchant Synthetic API
- Merchant Biotech API
By Therapeutic Application, the North America market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section.
- Infectious Diseases
- Oncology
- Ophthalmology
- Cardiovascular Disorders
- Central Nervous System
- Pulmonary Disorders
- Orthopedics
- Other Applications
By Drug Type, the North America market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section.
- Branded Prescription Drugs
- Generic Prescription Drugs
- OTC Drugs
Geographically, the following national/local markets are fully investigated:
- U.S.
- Canada
- Mexico
For each key country, detailed analysis and data for annual revenue ($ bn) are available for 2018-2028. The breakdown of key national markets by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
- AbbVie Inc.
- Astrazeneca
- Aurobindo Pharma Ltd.
- BASF
- Bayer AG
- Boehringer Ingelheim
- Catalent Inc.
- Dr. Reddy’s Laboratories
- F. Hoffmann-La Roche
- GlaxoSmithKline plc
- Lonza Group
- Lupin Limited
- Merck & Co., Inc.
- Mylan NV
- Novartis International AG
- Pfizer Inc.
- Sanofi
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/r/6vgsws
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900